PRP in Hiatal Hernia Repair (PPR-HHR Trial)
Palo Alto (17 mi)Age: 18+
Sex: Any
Travel: May be covered
Time Reimbursement: Varies
Trial Phase: N/A
Waitlist Available
Sponsor: University of Southern California
No Placebo Group
Approved in 2 jurisdictions
Trial Summary
What is the purpose of this trial?This trial is testing whether using platelet rich plasma (PRP) with mesh in hiatal hernia surgery can improve healing and reduce hernia recurrence. The study involves adults with large hernias and looks at the effects of PRP on healing and recurrence rates. PRP is believed to enhance tissue healing, making the repair stronger. Platelet-rich plasma (PRP) has been underinvestigated for improving hernia repair outcomes, but it may enhance healing and reduce recurrence rates.
Eligibility Criteria
This trial is for adults with large hiatal hernias over 5cm, confirmed by specific imaging tests. It's not suitable for non-English speakers, those who've had previous antireflux surgery, diabetics, recent steroid users or cancer patients, pregnant or breastfeeding women, smokers, and people with low platelet counts or platelet dysfunction.Exclusion Criteria
I have had surgery to prevent acid reflux.
I have been treated for cancer or had active cancer in the past year.
Treatment Details
The study compares the effectiveness of using Platelet Rich Plasma (PRP) in mesh repair of hiatal hernias against standard mesh repair without PRP. Participants are randomly assigned to either group and followed up for a year to check for hernia recurrence and quality of life related to acid reflux.
2Treatment groups
Experimental Treatment
Active Control
Group I: PRPExperimental Treatment1 Intervention
Patients in this treatment arm will have PRP injected into the crura of the diaphragm and coating the mesh placed during the hiatal hernia repair.
Group II: No PRPActive Control1 Intervention
Patients in this arm will undergo an identical surgical procedure, however will not have the addition of PRP injected into the cura of the diaphragm or onto the mesh placed during the hiatal hernia repair.
Platelet Rich Plasma is already approved in United States, European Union for the following indications:
๐บ๐ธ Approved in United States as Platelet Rich Plasma for:
- Facet-mediated lumbar low back pain
- Degenerative joint disease
- Chronic pain
๐ช๐บ Approved in European Union as Platelet Rich Plasma for:
- Orthopedic conditions
- Musculoskeletal disorders
- Pain management
Find a clinic near you
Research locations nearbySelect from list below to view details:
Keck Hospital of USCLos Angeles, CA
Hoag HospitalNewport Beach, CA
Loading ...
Who is running the clinical trial?
University of Southern CaliforniaLead Sponsor